| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |